Enhancement and antibody-mediated rejection of mouse skin allografts with anti-H-2K, H-2D, H-2L antibodies
Capel, P.J.; de Waal, R.M.; Démant, P.; Koene, R.A.
Transplantation Proceedings 13(1 Part 1): 649-653
1981
ISSN/ISBN: 0041-1345 PMID: 7268885 Document Number: 172872
Document emailed within 1 workday
Related Documents
Capel, P.J.; Tamboer, W.P.; de Waal, R.M.; Jansen, J.L.; Koene, R.A. 1979: Passive enhancement of mouse skin allografts by alloantibodies is Fc dependent Journal of Immunology 122(2): 421-425Gustavsson, M.L.; Gannedahl, G.; Bäcker, A.E.; Larson, G.; Olling, A.; Tufveson, G.; Samuelsson, B.E. 1996: Anti-carbohydrate antibodies associated with hyperacute rejection in a vascularized mouse heart-to-rat xenotransplantation model Transplantation 61(6): 957-963
McLigeyo, S.O.; Notghi, A.; Anderton, J.L.; Dick, J. 1990: Acute renal allograft rejection: the role of monoclonal antibodies in treatment: experience with orthoclonal anti-T3 cell antibody East African Medical Journal 67(9): 667-673
Bhan, A.K.; Mihm, M.C.; Dvorak, H.F. 1982: T cell subsets in allograft rejection. in situ characterization of T cell subsets in human skin allografts by the use of monoclonal antibodies Journal of Immunology 129(4): 1578-1583
Ohtsuka, K.; Yasunami, Y.; Ikehara, Y.; Nagai, T.; Kodama, S.; Maki, T.; Tomita, A.; Abo, T.; Ikeda, S. 1997: Expansion of intermediate T cell receptor cells expressing interleukin-2 receptor alpha- beta+, CD8alpha+ beta+, and lymphocyte function-associated antigen-1+ in the liver in association with intrahepatic islet xenograft rejection from rat to mouse: prevention of rejection with anti-interleukin-2 receptor beta monoclonal antibody treatment Transplantation 64(4): 633-639
Gautreau, C.; Suberbielle, C.; Andrade, J.; Charron, D. 2006: Donor-specific antibody detection for diagnosis of antibody-mediated rejection in kidney transplantation Clinical Transplants 2006: 502
Vossen, A.C.; Tibbe, G.J.; van Oudenaren, A.; Vredendaal, A.E.; Benner, R.; Savelkoul, H.F. 1994: A rat anti-mouse CD3 monoclonal antibody induces long-term skin allograft survival without inducing side effects Transplantation Proceedings 26(6): 3157-3158
Yoshimura, R.; Chargui, J.; Aitouche, A.; Veyron, P.; Touraine, J.L. 2000: Induction of hyperacute rejection of skin allografts by CD8+ lymphocytes Transplantation 69(7): 1452-1457
Holter, A.R.; McKearn, T.J.; Neu, M.R.; Stuart, F.P. 1972: Abrogation of hyperacute rejection of renal allografts by pepsin digest fragments of antidonor antibody Surgical Forum 23(0): 280-281
Briscoe, D.M.; Dharnidharka, V.R.; Isaacs, C.; Downing, G.; Prosky, S.; Shaw, P.; Parenteau, N.L.; Hardin-Young, J. 1999: The allogeneic response to cultured human skin equivalent in the hu-PBL-SCID mouse model of skin rejection Transplantation 67(12): 1590-1599
Kitamura, K. 2005: Duffy blood groups and their antibodies (anti Fy(a) antibody, anti Fy(b) antibody) Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 7): 690-691
Hancock, W.W.; Sablinski, T.; Milford, E.L.; Tilney, N.L.; Atkins, R.C.; Kupiec-Weglinski, J.W. 1990: Beneficial effects of monoclonal antibody targeting of CD4+ cells during the sensitisation but not effector phase of accelerated rejection of rat cardiac allografts Transplantation Proceedings 22(5): 2115-2116
Fagbami, A.H.; Halstead, S.B. 1986: Antibody-mediated enhancement of Wesselsbron virus in P388D1 cells African Journal of Medicine and Medical Sciences 15(3-4): 103-107
McKenzie, I.F.; Koene, R.; Winn, H.J. 1971: Mechanism of skin graft enhancement in the mouse Transplantation Proceedings 3(1): 711-713
Haiyan, X.; Xiaozhou, H.; Wei, Z.; Hui, G.; Qianqian, S.; Yibei, Z.; Xueguang, Z. 2012: CD256 Can be Found in Antibody-Mediated Renal Allograft Rejection Tissues Clinical Laboratory 58(5-6): 411-418
Lubetzky, M.; Auli, M.J.; Walker, J.; Leeser, D.; Kapur, S.; Hartono, C.; Dadhania, D. 2010: Reduction in proteinuria with bortezomib based therapy for antibody mediated rejection Clinical Transplants 2010: 437-440
Bemelmans, M.H.; Abramowicz, D.; Gouma, D.J.; Goldman, M.; Buurman, W.A. 1994: In vivo T cell activation by anti-CD3 monoclonal antibody induces soluble TNF receptor release in mice. Effects of pentoxifylline, methylprednisolone, anti-TNF, and anti-IFN-gamma antibodies Journal of Immunology 153(2): 499-506
Garovoy, M.R.; Suthanthiran, M.; Gailiunas, P.; Carpenter, C.B.; Graves, M.; Busch, G.; Tilney, N.L. 1978: Anti-Ia antibody eluted from rejected human renal allografts Transplantation Proceedings 10(3): 613-616
Hardinger, K.L.; Alford, K.; Murillo, D. 2010: Bortezomib as rescue therapy for antibody mediated rejection: a single-center experience Clinical Transplants 2010: 429-436
Wong, W.; Lee, R-Ann.; Saidman, S.L.; Smith, R.Neal.; Zorn, E. 2009: Bortezomib in kidney transplant recipients with antibody mediated rejection: three case reports Clinical Transplants 2009: 401-405